Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers

Cancer Letters

Volumn 103, Issue 1, 1996, Pages 115-121

  Nelson, Mark A ^a,c   Wymer, Julie ^a   Clements Jr , Neil ^a,b,d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Pulmonary Practice   (United States)

Author keywords

Biomarker; Field cancerization; K ras; Kirsten Ras; Lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG PARENCHYMA; MALE; MUTATION RATE; ONCOGENE K RAS; PRIORITY JOURNAL;

EID: 0029983092     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04202-4     Document Type: Article

References (25)

1. Slaughter, D.P., Southwick, H.W., and Smejkal, W. (1953) Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer, 6, 963-968.
2. Hong, W.K. and Lippman, S.M. (1991) Chemoprevention of aerodigestive epithelial cancers. In: Chemoimmuno Prevention of Cancer. Editors: U. Pastorino and W. Hong. George Thieme Verlag, Stuttgart, pp. 141-146.
3. Benner, S.E., Lippman, S.M. and Hong, W.K. (1992) Chemoprevention strategies for lung and upper aerodigestive tract cancer. Cancer Res, 52, 2758s-2763s.
4. Minna, J.D., Kaye, F.J., Takahashi, T. et al. (1989) Recessive oncogenes and chromosomal deletions in human lung cancer. In: Recessive Oncogenes and Tumor Suppression. Editors: W. Cavanee, N. Hastie and E. Standbridge Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 57-65.
5. Barbacid, M. (1987) Ras genes. Annu. Rev. Biochem., 56, 779-827.
6. Rodenhuis, S., Wetering, M.L.v.d., Mooi, W.J., Evers, S.O., Zandwijk, N.v. and Bos, J.L. (1987) Mutational activation of the K-ras oncogene: a possible pathogenic factor in adenocarcinoma of the lung. N. Engl. J. Med., 317, 929-935.
7. Reynolds, S.H., Anna, C.K., Brown, K.C., Wiest, J.S., Beattie, E.J., Pero, R.W., Iglehart, J.D. and Anderson, M.W. (1991) Activated proto-oncogenes in human lung tumors from smokers. Proc. Natl. Acad. Sci. USA, 88, 1085-1089.
8. Mitsudomi, T., Viallet, J., Mulshine, J.L., Linnoila, R.I., Minna, J.D. and Gazdar, A.F. (1991) Mutations of ras genes distinguish a subset of non-small cell lung cancer cell lines from small cell lung cancer cell lines. Oncogene, 6, 1353-1362.
9. Slebos, R.J.C., Kibbelaar, R.E., Dalesio, O. et al. (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323, 561-565.
10. Mitsudomi, T., Steinberg, S.M., Oie, H.K., Mulshine, J.L., Phelps, R., Viallet, J., Pass, H., Minna, J.D. and Gazdar, A.F. (1991) Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res., 51, 4999-5002.
11. Nelson, M.A., Futscher, B.W., Kinsella, T., Wymer, J. and Bowden, G.T. (1992) Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl Acad. Sci. USA, 89, 6398-6402.
12. Nelson, M.A., Einsphar, J., Alberts, D.S., Balfour, C., Wymer, J.A., Salasche, S., Bangert, J., Grogan, T.M. and Bozzo, P. (1994) Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett., 85, 23-29.
13. Neri, A., Knowles, D.M. Greco, A., McCormick, F. and Dalla-Favera, R. (1988) Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc. Natl. Acad. Sci. USA, 85, 9268-9272.
14. Leibovitz, A., Wymer, J., Massey, K., Thompson, F.H. and Nelson, M.A. (1994) Establishment of a new lung sarcoma cell line from a human lung carcinosarcoma. Cancer Lett., 82, 145-152.
15. Clements, N.C., Nelson, M.A., Wymer, J.A., Savage, C., Aguirre, M. and Garewal, H. (1996) Analysis of K-ras gene mutations in malignant and nonmalignant endobronchial tissue obtained by fiberoptic bronchoscopy. Am. J. Resp. Crit. Care Med., in press.
16. Society, A.C. (Editor) (1992) Cancer Facts and Figures. Atlanta, GA.
17. Newcomb, P. and Carbone, P.P. (1992) The health consequences of smoking: cancer. Med. Clin. North Am., 76, 305-331.
18. van Mansfeld, A.D.M. and Bos, J.L. (1992) PCR-based approaches for detection of mutated ras genes. PCR Methods Appl. 1, 211-216.
19. You, M., Candrian, U., Maronpot, R.R., Stoner, G.D. and Anderson, M.W. (1989) Activation of the K-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. USA, 86, 3070-3074.
20. Mao, L., Hruban, R.H., Boyle, J.O., Tockman, M. and Sidransky, D. (1994) Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res., 54, 1634-1637.
21. Brown, K., Buchmann, A. and Balmain, A. (1990) Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. USA, 87, 538-542.
22. Kumar, R., Sukumar, S. and Barbacid, M. (1990) Activation of ras oncogenes preceding the onset of neoplasia. Science, 248, 1101-1104.
23. Sklar, M. (1988) Increased resistance to cis-diammine-dichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res. 48, 793-797.
24. Sklar, M. (1988) The ras oncogene increases the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science, 239, 793-797.
25. Foulds, L. (1965) Multiple etiologic factors in neoplastic development. Cancer Res., 25, 1339-1347.